About 95 percent of America’s 34 million smokers who attempt to stop on their own fail. Now a new study underway in South Florida and a total of 15 states and around the country is recruiting those who’ve smoked at least 10 cigarettes a day for a year, have made at least one attempt to stop smoking and are motivated to stop. Led locally by the Alliance for Multispecialty Research, the study embraces the plant-based medication known as cytisinicline, which has been authorized by regulators in Central and Eastern Europe for two decades.
One of the key trial site organizations associated with this study, the Alliance for Multispecialty Research, recently introduced the topic in the local media, 10 WPLG. The research organization’s Dr. Jeffrey Rosen leading the Florida site (Coral Gables) declared, “This new medication is a plant-based medication. It’s been in Europe for over two years, it has a long name called cytisinicline, but we’ll call it cystine. And that’s the medication we’re testing and comparing to two different lengths of treatment versus placebo.”
In Europe, the success rate of the medication has been about 30 percent, compared with three currentl...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).